Cardiac health and cholesterol are interconnected factors crucial for heart disease risk and overall cardiovascular well-being. Cholesterol, a vital fat, can lead to artery plaque buildup and heart disease if elevated, especially LDL cholesterol. Balancing cholesterol levels with low LDL and high HDL cholesterol is key, as HDL can reduce heart disease risk by removing excess cholesterol. Elevated LDL, low HDL, and high triglycerides can raise atherosclerosis risk, leading to artery plaque buildup and heart-related issues. Monitoring cholesterol levels via blood tests is essential to assess heart health and identify heart disease risks.
Sort by title | Sort by title | Sort by price | Sort by price
The aldosterone-to-renin ratio test measures the levels of aldosterone and renin in the blood and calculates the ratio between the two. It is used to diagnose conditions like primary aldosteronism, where excess aldosterone production leads to high blood pressure and low potassium levels. A high ratio may indicate this condition, and treatment options include medications or surgery. Healthcare providers interpret the results alongside other clinical findings and tests.
The Apo-B test measures the level of apolipoprotein B in the blood, a protein found on LDL cholesterol particles. Elevated levels are linked to cardiovascular disease risk due to increased LDL particles that can lead to artery plaque. The test is used alongside lipid tests to assess heart disease risk and guide treatment decisions, especially for individuals with family history or risk factors.
A Basic Heart Health Panel Blood Test assesses key markers related to cardiovascular function, identifying risk factors for heart disease and evaluating cardiac health. Common components include tests for cholesterol levels (LDL, HDL, total cholesterol, and triglycerides), lipid profile, C-reactive protein (CRP) for inflammation, fasting blood glucose, and hemoglobin A1c for average blood sugar levels. This panel helps healthcare providers evaluate cardiovascular risk, create personalized treatment plans, and monitor heart health over time.
The BNP test measures levels of the hormone BNP in the blood, which is produced by the heart in response to increased pressure or volume. It is used to diagnose and monitor heart failure, differentiate between heart failure and other conditions, assess the severity of heart failure, and guide treatment decisions.
C-Reactive Protein (CRP) is produced by the liver in response to inflammation, with high levels indicating inflammation from infection, injury, or chronic conditions. High Sensitivity CRP testing is more sensitive in detecting small increases in CRP levels to identify low levels of inflammation missed by standard tests. Elevated CRP levels, especially detected sensitively, may indicate increased cardiovascular disease risk due to inflammation's role in atherosclerosis.
Coenzyme Q10 (CoQ10) is a natural nutrient in the body essential for energy production and acts as an antioxidant. A CoQ10 blood test can help diagnose deficiencies, often caused by medical conditions, medications, or diet. Symptoms of deficiency include fatigue and muscle weakness. Treatment may include CoQ10 supplements or dietary changes.
The Comprehensive Heart Health Panel is a thorough set of tests evaluating key factors related to heart health and overall cardiovascular function. It assesses markers associated with heart disease risk, cardiac function, and overall cardiovascular wellness. Components may include cholesterol and lipid tests, cardiac enzymes, electrolyte levels, blood pressure monitoring, blood glucose testing, inflammatory markers, thyroid function tests, and coagulation studies. This comprehensive panel offers healthcare providers insights into an individual's heart health, aids in identifying risk factors, and supports the development of personalized treatment plans. It plays a crucial role in preventive medicine, early detection of heart conditions, and informed decisions about cardiovascular well-being following discussion of the results with healthcare providers.
Creatine kinase (CK) is an enzyme crucial for energy metabolism found in muscles and tissues. Elevated CK levels in the bloodstream suggest muscle damage, heart stress, or inflammation. A total CK test measures overall CK levels and helps diagnose these conditions. Normal CK levels vary with age, gender, and activity level. Symptoms like muscle weakness or heart disease risk factors may prompt the test. Treatments for elevated CK levels depend on the cause and may include medications or lifestyle changes.
The ESR test measures how quickly red blood cells settle, indicating inflammation in the body. It can signal conditions like infections, autoimmune diseases, and cancer. The test is used to diagnose and monitor conditions such as rheumatoid arthritis and lupus. A high ESR level is not specific and may require further testing. The test involves drawing blood, which is left to settle in a tube, with results measured in mm/hr. Normal values vary by age and gender.
A homocysteine test measures levels of the amino acid homocysteine in the blood, which is produced during protein metabolism. High levels are linked to increased cardiovascular disease risk. The test is done after fasting and helps assess heart disease risk, especially in individuals with family history or risk factors. Normal levels are 5-15 umol/L, and higher levels may require further evaluation by a healthcare provider. Factors like medications and nutrient levels can influence results, so interpretation should consider overall health status.
A lipid panel, also known as a cholesterol panel, is a blood test that measures different types of fats in your blood, such as cholesterol and triglycerides. This test assesses your risk for heart disease and identifies abnormal cholesterol levels that may require treatment. The panel includes measurements of total cholesterol, LDL (bad) cholesterol, HDL (good) cholesterol, and triglycerides. Results are reported in mg/dL, and your healthcare provider will interpret them to determine if further action or treatment is needed based on your individual health profile.
The Lp(a) test measures levels of lipoprotein (a) in the blood, which is associated with increased risk of cardiovascular disease. It is recommended for individuals with a family history of heart problems. This test is often part of a lipid panel and results are reported in mg/dL. Treatment for high levels may include lifestyle changes and medication, tailored to individual risk factors and test results.
The Lipoprotein Analysis (NMR) test measures different lipoprotein particles in the blood, providing detailed information about size and density. It is used to assess cardiovascular risk more comprehensively than traditional cholesterol tests, helping healthcare providers understand cholesterol profiles and make informed treatment decisions. The test is often ordered for individuals with cardiovascular risk factors and can monitor the effectiveness of cholesterol-lowering medications or lifestyle changes. Overall, the test provides a personalized assessment of cardiovascular risk to tailor treatment plans for patients.
Prothrombin Time (PT) with International Normalized Ratio (INR) is a test measuring blood clotting time. PT measures liquid blood clotting time, while INR standardizes clotting time across labs. High PT/INR indicates bleeding risk, low indicates clotting risk. Used to monitor blood-thinning medication, diagnose clotting disorders, and assess liver function.
Microalbuminuria is a condition characterized by elevated albumin levels in urine, indicating kidney damage, often linked to diabetes, hypertension, or certain medications. Monitoring microalbumin levels can aid in early detection and management of kidney disease, with treatment typically involving lifestyle adjustments, medication, and regular kidney function monitoring.
A Standard Heart Health Panel is a series of tests designed to assess key factors related to cardiovascular health and heart function. The panel helps healthcare providers evaluate an individual's risk of heart disease, monitor cardiac health, and determine appropriate treatment plans. Common components include tests for cholesterol levels, lipid profile, cardiac enzymes like troponin, electrolytes, blood pressure, blood glucose, C-reactive protein (CRP), and thyroid function. These tests provide a comprehensive evaluation of cardiovascular health, aiding in risk identification, heart disease diagnosis, and personalized care. They are essential for preventive care, early heart disease detection, and overall cardiovascular well-being.
Regular monitoring of cholesterol levels, including LDL, HDL, and triglycerides, as well as liver function and creatine kinase tests, is essential for individuals on statin therapy to assess the risk of heart disease and potential side effects.
A troponin cardiac test measures troponin levels in the blood, a protein released during heart muscle damage like a heart attack. Elevated levels can signal a recent heart attack or cardiac problems, often used with other tests for diagnosis and monitoring heart conditions.